MD&A Q3_2020 (Eng ) November 2, 2020 Subject : Interim Management Discussion and Analysis of Q3/2020 Attention : President of The Stock Exchange of Thailand We attach herewith the financial
April 27th, 2021 No. ACC/HO 008/64 Topic: Management Discussion and Analysis for the Quarter of 1/2021 To: President The Stock Exchange of Thailand During the first quarter of 2021 a new wave of
Page 1 of 3 GEL.CS.001/2563 2 March 2020 Subject: Management Discussion and Financial Analysis for the operating results as at December 31, 2019 To: Director and Manager The Stock Exchange of
Microsoft Word - MD&A-E-mh-FA-nn.docx 1 Ref: CSO 016/2020 Date: 7th May 2020 Subject: Management Discussion and Analysis Quarter 1 Ending 31st March 2020 Attention: President The Stock Exchange of
Page 1 of 4 No. RJH – SET 7/2020 11 May 2020 Subject : Management’s Discussion and Analysis for the First Quarter of 2020 To : The President The Stock Exchange of Thailand Rajthanee Hospital Public
Ref. No. IVL 002/05/2020 12 May 2020 The President The Stock Exchange of Thailand Subject: Submission of Quarterly Review of Financial Statements and the Management Discussion and Analysis of
Microsoft Word - Operating Result for the first quarter of 2020 SBN 010/2020 May 14, 2020 Subject : Operating Result for the first quarter of 2020 To : The Managing Director, The Stock Exchange of
1 June 30, 2020 Subjects : The acquisition of ordinary shares of APEX Energy Co., Ltd. increased 18.75% Attention : The Director and Manager of the Stock Exchange of Thailand Eastern Power Group
August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
Exchange of Thailand Dimet (Siam) Public Company Limited “company” would like to notify on qualified opinion from auditor as shown in Noted to Financial Statement due to authorized directors of ASIAN